We have identified a Drosophila transcription factor that binds to fat body-specific enhancers of alcohol dehydrogenase {Adh) and yolk protein genes. DNA sequence analysis of cDNA clones encoding this protein, box B-binding £actor-2 (BBF-2), indicates that it is a member of the CREB/ATF family of transcriptional regulatory proteins. A number of observations suggest that BBF-2 is involved in fat body-specific expression: Mutations that disrupt BBF-2 binding to two different Adh fat body enhancers in vitro decrease the activity of these enhancers in transgenic flies. BBF-2 mRNA is present in all cell types examined, and the protein is present in cells that express ADH. Finally, BBF-2 is a transcriptional activator in Drosophila tissue culture cells. Remarkably, BBF-2 also binds specifically to regulatory elements required for liver-specific expression of the human Adh and rat tyrosine aminotransferase genes. Thus, BBF-2 and the DNA sequence to which it binds may be important components of a tissue-specific regulatory mechanism conserved between Drosophila and man.
The alcohol dehydrogenase [Adh] genes of Drosophila have provided an excellent system for studying the mechanisms that control tissue-specific gene expression. The Drosophila melanogaster Adh gene is transcribed during embryogenesis, larval development, and in adults, and it is expressed in a specific set of tissues that includes the fat body, gut, and reproductive organs (Ursprung et al. 1970; Savakis et al. 1986; Lockett and Ashburner 1989) . The pattern of Adh tissue-specific expression varies from species to species, but all species thus far examined express Adh in the larval and adult fat body (Dickinson 1980a (Dickinson ,b, 1988 Batterham et al. 1983; Rabinow and Dickinson 1986) .
The sequences required for tissue-specific and temporal expression of the Adh genes of two distantly related species, D. melanogaster and Drosophila muUeri, have been determined using P-element-mediated transformation of D. melanogaster (Fischer and Maniatis 1986, 1988; Corbin and Maniatis 1989a,b, 1990) . The D. melanogaster Adh gene is expressed from two promoters: the proximal promoter primarily active in larvae, and the distal promoter primarily active in adults (Benyajati et al. 1983) . In contrast, the D. muUeriAdh locus contains two functional genes: one that is expressed in larvae and one that is expressed in adults [Adh-2) Fischer and Maniatis 1985, 1986) . These genes produce two distinct ADH proteins (Oakeshott et al. 1982; Batterham et al. 1983 Batterham et al. , 1984 .
Expression of Adh in adults and larvae in both species is regulated by distinct fat body-specific enhancers, and three of these enhancers have been characterized in detail. The D. melanogaster Adh adult fat body enhancer (AAE; Corbin and Maniatis 1989a ) is a 140-bp element located -500 bp upstream from the distal promoter (Falb 1991) . The AAE acts to stimulate transcription from the distal promoter in adults (Corbin and Maniatis 1989a) . The D. muUeri adult enhancer is located -2500 bp upstream of the Adh-2 promoter, near the 5' end of an adult pseudogene (Fischer 1987; Falb 1991) . The D. mulleri larval fat body enhancer, box B, is a 90-bp regulatory element located -200 bp upstream of the Adh-1 gene . Box B drives expression of the Adh-1 gene in larvae. Both box B and the AAE act as fat body-specific enhancers when linked to a heterologous promoter. In association with the appropriate promoter elements, however, these enhancers also direct expression in three other tissues (Fischer and Maniatis 1988a; Falb 1991 ). An adult fat body enhancer that regulates the expression of the Drosophila yolk protein genes ypl and yp2 has also been characterized (Garabedian et al. 1985 (Garabedian et al. , 1986 . This enhancer is located in a region that lies between the divergently transcribed ypl and yp2 genes. In summary, four distinct fat body enhancers have been characterized in Drosophila: the Adh adult enhancers of D. melanogaster and D. mulleri, the Adh larval enhancer of D. mulleri, and the fat body-specific enhancer for ypl and yp2. To investigate the mechanisms responsible for the coordinate regulation of these fat body enhancers, we have identified and characterized a transcription factor that recognizes a sequence present in all four fat body enhancers. This transcription factor was initially cloned from a D. melanogaster cDNA library on the basis of its ability to bind specifically to the box B element of the fat body enhancer of the D. mulleh Adh-1 gene [box B-binding factor-2 (BBF-2)]. Remarkably, BBF-2 also binds specifically to the three other Drosophila fat body-specific enhancers and to sequences required for liver-specific expression of the human Adh ) and tyrosine amino transferase genes .
DNA sequence analysis of BBF-2 cDNA clones reveals that its DNA-binding domain contains a basic region that is similar to that of the CREB/ATF family of transcriptional regulatory proteins. Thus, BBF-2 and a mammalian CREB/ATF protein bind to sites that are critical for fat body-and liver-specific gene expression. Therefore, it appears that the role of CREB/ATF proteins in tissue-specific gene expression has been conserved between Drosophila and man.
Results

BBF-2 contains a DNA-binding domain similar to that of mammalian CREB/ATF proteins
A cDNA clone encoding a protein that binds specifically to box B of the D. mulleri Adh-1 gene was isolated by screening a D. melanogaster 9-to 12-hr embryonic \gtl 1 cDNA library (Zinn et al. 1988 ) with a probe containing multiple copies of box B (Singh et al. 1988; Vinson et al. 1988 ). This library was chosen because the fat body begins to form during this stage of embryogenesis (Poulsen 1950) and Adh is first expressed at this time (Fischer and Maniatis 1986; Savakis et al. 1986) . A D. melanogaster library was chosen because all studies of the cis-acting regulatory elements of the D. mulleri Adh locus were performed using P-element-mediated transformation of D. melanogaster (Fischer and Maniatis 1986, 1988) . Initially, a phage clone containing a 2.2-kb cDNA insert was obtained (X.BBF-2). Bacterial cell extracts prepared from IPTG-induced \BBF-2 lysogens contained a specific box B-binding activity as judged by gel retardation assays and competition experiments (data not shown).
Preliminary sequence analysis of the initial isolate, \BBF-2, revealed that it lacked a translational initiation codon. To obtain cDNA clones containing the entire coding region, we screened the 9-to 12-hr embryonic \gtll cDNA library (Zinn et al. 1988 ) and a 12-to 24-hr embryonic library (Brown and Kafatos 1988) using the XBBF-2 insert as a hybridization probe. Several overlapping cDNA clones that span 3.1 kb of sequence were isolated. The complete nucleotide sequence of these clones was determined and found to contain the entire coding region, which spans 1545 bp, encoding a protein of 515 amino acids with a predicted molecular mass of 56 kD (Fig lA) .
The longest cDNA clone characterized includes 929 and 644 bp of 5'-and 3'-untranslated region, respectively. The length of this 5'-untranslated region is unusual, and it contains multiple short AUG-initiated open reading frames (ORFs), each of which ends with a stop codon within this leader sequence. Several mRNAs known to be translationally regulated also possess multiple ORFs in their 5'-untranslated regions (e.g., GCN4; Mueller and Hinnebusch 1986) . The AUG that most closely fits the consensus sequence for Drosophila translational initiation sites (Cavener 1987) is the AUG at nucleotide 929, which initiates an ORF of 515 amino acids. The use of this AUG was confirmed by in vitro translation of various RNA templates using rabbit reticulocyte lysate (data not shown). The 644-bp 3'-untranslated region does not contain a good match to the AAUAAA polyadenylation signal, and it ends in a stretch of only 10 A residues. Thus, our 3'-most cDNA clone may not contain the 3' end of BBF-2 mRNA, possibly explaining the difference between the size of BBF-2 mRNA detected in Northern blotting experiments (4.3 kb; Fig. 4A , below) and the size of our cDNA (3.1 kb).
In situ hybridization to polytene chromosomes localized the gene encoding BBF-2 to the second chromosome at cytological position 25C/D (data not shown). Southern blot analysis at high stringency revealed a simple pattern of bands, supporting the conclusion that BBF-2 is either a single-copy gene or a member of a small gene family (data not shown).
Examination of the encoded amino acid sequence and a search of the GenBank data base revealed a basic region located near the carboxyl terminus of BBF-2 that is similar to that of the bZIP superfamily of DNA-binding proteins (Fig. IB; Landschulz et al. 1988b; Vinson et al. 1989) . The bZIP superfamily of proteins is extensive and includes C/EBP (Landschulz et al. 1988a (Landschulz et al. , 1989 , c-Fos (Lee et al. 1987) , c-Jun (Bohmann et al. 1987) , GCN4 (Arndt and Fink 1986) , ATF (Hai et al. 1989) , and CREB (Hoeffler et al, 1988; . Recently, Perkins et al. (1990) isolated cDNAs encoding Drosophila homologs (dFRA and dJRA) of the mammalian Fos and Jun proto-oncogenes. All of these proteins possess a basic region, which is responsible for DNA binding, followed by a heptad repeat of leucine residues, termed the leucine zipper, which mediates dimerization (for review, see Abel and Maniatis 1989) . As shown in Figure IB , the basic region of BBF-2 is strikingly similar (66%) to that of the CREB/ATF subfamily. The basic region of BBF-2 is also closely related to other members of the bZIP family: This 40-amino-acid portion of BBF-2 is 58% similar to the corresponding region of c-Fos, 53% similar to Drosophila Fos-related antigen (dFRA), 57% similar to Drosophila Jun-related antigen (dJRA), and 42% similar to the basic domain of C/EBP. Thus, the basic region of BBF-2 is most closely related to that of the mammalian transcription factors CREB and ATF-1. The leucine repeat of BBF-2 extends for five heptad repeats but is interrupted by the replacement of the third leucine residue by tyrosine. Like the mammalian CREB/ATF proteins, BBF-2 forms dimers in solution and an intact leucine zipper is required for dimer formation (T. Abel and T. Maniatis, unpubl.) The similarity between BBF-2 and other bZIP 
BBF-2 binds to box B and three other fat body-specific enhancers
To determine the region of box B contacted by BBF-2, we carried out DNase I footprinting experiments. As shown in Figure 2 , recombinant BBF-2 protein produced in bacteria protects a 23-bp region extending from -269 to -246 of the Adh-1 promoter from DNase I cleavage.
Expression of the Drosophila Adh loci is controlled by enhancer elements that are fat body specific: In D. mulleri they include box B and the adult enhancer, and in D. melanogaster, the AAE. The Drosophila yolk protein genes also contain a well-characterized fat body-specific enhancer. To determine whether BBF-2 could be involved in the coordinate regulation of these tissue-specific enhancers, we investigated the ability of recombinant BBF-2 to bind to these sequences using DNase I footprinting experiments.
As shown in Figure 2 , BBF-2 specifically protects a region of the AAE from DNase I cleavage. BBF-2 has approximately equal affinity for its binding sites within box B and the AAE as judged by DNase I footprinting experiments in which a varying amount of recombinant BBF-2 was added (data not shown). A BBF-2-binding site is also located within the D. muUeri adult enhancer (Fig.  2) , which directs expression of the Adh-2 gene, although BBF-2 binds about threefold less well to this sequence than to box B and the AAE.
A 125-bp element located between the two Drosophila yolk protein genes functions as a fat body-specific enhancer, stimulating high levels of transcription from a heterologous promoter in the fat body of adult females (Garabedian et al. 1985 (Garabedian et al. , 1986 . In DNase I footprinting experiments shown in Figure 2 , BBF-2 protects a region of the yolk protein gene fat body enhancer from DNase I cleavage. BBF-2 binds to the yolk protein gene fat body enhancer and the D. mulleri Adh adult enhancer with approximately equal affinity.
Ovarian nuclear extracts contain BBF-2
The AAE is required for the normal pattern of expression of the D. melanogaster distal promoter. In particular, this regulatory element is required for expression in ovaries (Corbin 1989) . In a gel retardation assay using ovarian nuclear extract, we detected three specific complexes with a probe containing the BBF-2-binding site (Fig. 3 and data not shown). One of these complexes comigrates with a DNA-protein complex formed with the same DNA probe and full-length recombinant BBF-2 protein produced in bacteria. Additional evidence that BBF-2 is present in these complexes is provided by the demonstration that antiserum specific for BBF-2 blocks the formation of all three complexes (Fig. 3) . Preimmune antiserum ( Fig. 3 ) and antiserum to other DNA-binding proteins (data not shown) have no effect on the formation of these complexes. Consistent with these observations, BBF-2 mRNA was detected in mRNA prepared from dissected ovaries (T. Abel, M. Shea, F. Kafatos, and T. Maniatis, unpubl.) . We conclude that BBF-2 is present in the ovaries, an adult tissue that expresses Adh. (Hoeffler et al. 1988) , ATF-1 (Hai et al. 1989 ), c-Jun (Maki et al. 1987 ), c-Fos (Curran et al. 1982) , C/EBP (Landschulz et al. 1988a) , dFRA, and dJRA (Perkins et al. 1990 ). The identity of the protein is designated at left, and the numbers preceding each sequence correspond to the first amino acid residue. The consensus sequence shown at the bottom is from Vinson et al. (1989) , where dashes indicate nonconserved positions. Vertical lines indicate residues that are identical between BBF-2 and CREB; two dots indicate conserved residues. The leucine residues of the heptad repeat are underlined. Garabedian et al. 1985 Garabedian et al. , 1986 . End-labeled probes containing each of these enhancers were incubated with increasing amounts (0.5-5 \xl, noted above each lane) of bacterial extracts containing BBF-2 fusion protein or 5 |xl of control bacterial extract (C) and then treated with DNase I. The products were then separated on a sequencing gel. The residues protected by BBF-2 are shown beside each autoradiograph as a shaded oval. mulleri ing P-element-mediated transformation, the D. mulleri Adh-1 gene is expressed in embryos and at higher levels in larvae (Fischer and Maniatis 1986, 1988) . The yolk protein gene fat body enhancer and the D. melanogastei Adh adult enhancer, however, are active only in adults (Garabedian et al. 1985 (Garabedian et al. , 1986 Corbin and Maniatis 1989a; Falb 1991) . To determine the relationship betMreen the temporal and tissue-specific activity of these enhancers and the expression of the gene encoding BBF-2, a blot containing poly( A) "^ RNA obtained from various developmental stages was hybridized to a probe prepared from the insert of the cDNA clone \BBF-2. The data presented in Figure 4A reveal that BBF-2 mRNA, which is 4.3 kb in length, is present throughout the life cycle of the fly, albeit at varying levels. The highest levels of BBF-2 mRNA are seen during embryogenesis (4-12 hr) and in adult males. The presence of BBF-2 throughout development is consistent with a role in regulating expression from those enhancers to which its binding has been demonstrated (Fig. 2 ).
The gene encoding BBF-2 is expressed throughout development and in multiple larval tissues including the fat body
The DNase I footprinting studies described above demonstrate that BBF-2-binding sites are found in several fat body-specific enhancers. To investigate the pattern of BBF-2 expression in different tissues, we extracted RNA from dissected tissues of early third-instar larvae and used RNase protection experiments to quantitate BBF-2 message levels (Fig. 4B) . We found that BBF-2 mRNA levels, which were determined relative to a-tubulin mRNA, are approximately equivalent in the trachea, fat body, and gut, although only the gut and fat body express Adh. BBF-2 mRNA and protein are also found in the ovaries, adult tissue that expresses Adh ( Fig.  3 ; data not shown).
Mutation of the BBF-2-binding site within two fat body-specific enhancers reduces expression in vivo
The binding site for BBF-2 within box B lies in the region of two linker substitution mutations (LS7 and LS8) that Figure 3. BBF-2 is present in ovarian nuclear extracts. Gel retardation assays of specific DNA-binding proteins in ovarian nuclear extract are shown. Before the addition of probe to the binding reaction, varying amounts of antiserum specific to BBF-2 (IMM) or preimmune antiserum (PRE) were added to the reaction mixture. After 20 min on ice, a labeled oligonucleotide containing the BBF-2-binding site from box B was added, and the reactions were incubated for an additional 20 min on ice. The bound (B) and free (F) probes were then separated by nondenaturing polyacrylamide gel electrophoresis and visualized by autoradiography. As a control, no antiserum was added to a binding reaction containing ovarian nuclear extract (0). Lane B is a binding reaction that contains bacterially produced full-length BBF-2. The three bound complexes marked with arrows are specific for BBF-2, as judged by competition experiments (data not shown). IcT? , 4-to 12-hr (4-12) and 12-to 24-hr (12-24) embryos, first (1st)-and third (3rd)-instar larvae, pupae, and adult males and females. These RNAs were fractionated on an agarose gel, transferred to nitrocellulose, and probed with radioactive DNA probes from BBF-2 or a-tubulin (Matthews et al. 1989) . The bands corresponding to these two mRNAs are marked with arrows. The locations of RNA markers (in kb) are shown at right. The level of BBF-2 mRNA was calculated relative to the tubulin control by densitometry of appropriately exposed autoradiograms. The relative level of BBF-2 mRNA at each developmental stage is shown in the histogram below.
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[B] Tissue distribution of BBF-2 mRNA. Two micrograms of total nucleic acid prepared from isolated early third-instar larval tissues or total larvae was incubated simultaneously with uniformly labeled BBF-2 and a-tubulin RNA probes. The protected fragments were separated on a 5% sequencing gel and are marked with arrows. The tissues from which the nucleic acids were isolated are shown above the autoradiograph. The level of BBF-2 mRNA in each tissue was determined relative to tubulin by densitometry of appropriately exposed autoradiograms. These levels are shown in the histogram below.
result in lower levels of Adh-1 expression in vivo (Fig. 5; . A gel retardation assay using probes prepared from these mutants established that recombinant BBF-2 binds ~20-fold less w^ell to these tM^o linker scanning mutations relative to wild-type box B sequences (Fig. 5) . Thus, the BBF-2-binding site within box B is a positive regulatory element.
To explore the role of the BBF-2-binding site within another fat body-specific enhancer, we used site-directed mutagenesis to modify the BBF-2 site within the 140-bp AAE, creating a construct called lsBBF-2. The mutation of this site abolished the binding of BBF-2 to the AAE as assayed by gel retardation analysis (Fig. 5) . The v^AE directs expression of an hsp70-lacZ fusion gene specifically in the fat body of P-element-transformed adults ( Fig. 5; Falb 1991) . When linked to the hsp70-lacZ iusion gene and introduced into flies via P-element-mediated transformation, the mutation of the BBF-2-binding site decreases the relative transcriptional level directed by the AAE by 4.4-fold (Fig. 5) . Thus, BBF-2-binding sites in two different Adh fat body-specific enhancers function as positive regulatory elements.
BBF-2 is a transciiptional activator
To determine whether BBF-2 can function as a transcriptional activator we carried out cotransfection experiments in cultured Drosophila cells (Krasnow et al. 1989 ). Figure 5 . The BBF-2-binding site within the AAE and box B is essential for fat body expression in transgenic fUes. Using sitedirected mutagenesis, the BBF-2 site within the AAE was mutated. This construct (LsBBF-2), in which the mutated AAE drives expression of a hsp70-lacZ fusion gene, was introduced into fhes using P-element-mediated transformation. Total nucleic acids were prepared from adults of several of these lines and from adults transformed with the wild-type AAE (AAE). Transcripts were detected using RNase mapping with probes for the hsp70-lacZ and a-tubulin messages. The relative transcription levels (RTLs) were calculated from densitometry of appropriately exposed autoradiograms and are shown here calculated relative to one of the AAE lines. Each bar represents the level of hs-lacZ transcripts calculated relative to tubulin for an individual transformant line. The linker-scanning mutagenesis of box B has been described, and the RTLs listed here are from . RTLs for Adh-1, LS7, and LS8 were calculated relative to one of the Adh-1 lines. Binding studies were carried out using probes from wild-type or mutant enhancers in gel retardation assays with recombinant full-length BBF-2. The binding of BBF-2 to the mutant enhancers was calculated relative to wild type by densitometry of appropriately exposed autoradiograms.
The BBF-2 cDNA clone was inserted in both orientations into the Drosophila expression vector pPac (Krasnow et al. 1989 ), creating a vector in which the Drosophila actin promoter drives expression of sense (pPacBBF-2) or antisense (pPacBBF-2a) BBF-2. Reporter plasmids were constructed that contain either box B (pBoxBCAT) or an oligonucleotide encompassing the BBF-2-binding site within box B (p28-merCAT) driving expression of the bacterial chloramphenicol acetyl transferase (CAT) gene. The effector plasmids were transiently cotransfected into Drosophila Schneider 2 cells along with a reporter plasmid. As controls, the Drosophila expression vector pPac lacking the BBF-2 cDNA insert and the reporter plasmid lacking any additional promoter sites (pD-33CAT; Krasnow et al. 1989) were used. As shown in Figure 6 , cotransfection of BBF-2 increases expression of a promoter containing either a single BBF-2-binding site (p28-merCAT; about sevenfold activation) or a single copy of box B (pBoxBCAT; about threefold activation). In the absence of cotransfected BBF-2, both reporter constructs exhibit some basal activity, consistent with the observation that BBF-2 mRNA is present at low levels in these tissue culture cells (data not shown). The intact box B element is more active than a single BBF-2-binding site in the absence of added BBF-2 expression plasmid. This observation is consistent with the results of the extensive linker scaiming mutagenesis studies , suggesting that box B contains multiple regulatory elements. Endogenous BBF-2 in Drosophila tissue culture appears to play a role in the activity of both a single BBF-2-binding site (p28-merCAT) and a single copy of box B (pBoxBCAT) because the cotransfection of an effector plasmid expressing antisense BBF-2 transcripts decreases these levels two-to threefold.
BBF-2 binds to two mammalian liver-specific regulatory elements
The identification of BBF-2-binding sites in several fat body-specific enhancers led us to search for sites in other known tissue-specific regulatory elements. The Drosophila fat body and the mammalian liver are functional analogs, both expressing Adh. The human Adh genes are expressed at high levels in the liver, and recent experiments have demonstrated that a region of the ADH2 promoter extending from -171 to -1-34 is sufficient to drive expression in hepatoma cells ). Gel retardation studies (Fig. 7 ) using this portion of the ADH2 promoter reveal that BBF-2 binds here. The affinity of BBF-2 for the human ADH2 promoter is about threefold less than its affinity for box B. The BBF-2-binding site was localized by sequence analysis and DNase I footprinting studies (data not shown) to the region between -62 and -72 (see Fig. 8 ). Interestingly, this region corresponds to a portion of the promoter protected from DNase I cleavage by proteins present in rat liver nuclear extract. Additionally, mutation of this site leads to a reduced level of expression from this promoter in hepatoma cells (Stewart et al. 1991) . Analysis of the hepatocyte-specific enhancer of the rat tyrosine aminotransferase (TAT) gene has demonstrated that it consists of two essential elements: a cAMP-responsive element (CRE), which is the target of Tse-1 repression, and a hepatocyte-specific element ). To explore whether BBF-2 is capable of binding to the CRE in this enhancer, we performed gel retardation assays. In these studies (Fig. 7) , BBF-2 binds to this enhancer element.
The regions bound by BBF-2 in each of these enhancers are aligned in Figure 8 along with two sites, found on the basis of sequence comparisons, in the Adh genes of two additional Drosophila species. These sites are shown schematically in Figure 9 . The consensus sequence based . BBF-2 binds to the human ADH-2 promoter and to the CRE contained in the rat tyrosine aminotransferase (TAT) gene. Gel retardation analysis of BBF-2 binding to a consensus CREB/ATF site (CRE), the human ADH2 promoter (Hu ADH2; Stewart et al. 1990) , and the cAMP-responsive element from the hepatocyte-specific enhancer of the rat tyrosine aminotransferase gene (TAT-CRE; Boshart et al. 1990 ). Binding to an oligonucleotide containing the BBF-2-binding site from box B is also shown (BBF-2). One or five microliters of bacterial extract containing recombinant BBF-2 was mixed with the appropriate probe, and the complexes were separated by native gel electrophoresis. Control lanes (C) contain extract prepared from bacteria bearing an expression plasmid which contains the BBF-2 insert cloned in the reverse (antisense) orientation.
on the best BBF-2-binding sites, T(A/C)NACGTAN(T/ G)C, is related to the binding sites for other bZIP proteins. In particular, the BBF-2 consensus contains a tetranucleotide core, ACGT, which resembles that of the CRE to which CREB binds. Indeed, BBF-2 binds to a probe containing a CRE (Fig. 7) , but with a 5-to 10-fold reduced affinity. It should also be noted that binding sites for C/EBP and AP-1, two other bZIP proteins, are found in the AAE (Falb 1991 ; D. Falb and T. Maniatis, this issue). In DNase I footprinting and gel retardation experiments, recombinant BBF-2 does not bind to these sites (data not shown).
Discussion
BBF-2 is the only known member of the CREB/ATF family of transcriptional activators in Drosophila
The DNA sequence of the BBF-2 cDNA clone indicates that the BBF-2 protein is similar to the mammalian CREB/ATF family of transcriptional regulatory proteins. Members of this family are characterized by their bipartite DNA-binding domains (Landschulz et al. 1989 ). This domain consists of a basic region that contacts DNA and an adjacent heptad repeat of leucine residues that mediates dimerization. BBF-2, a novel member of this family of DNA-binding proteins, contains a basic domain that most closely resembles that of mammalian CREB (Fig.  IB) . Indeed, BBF-2 is able to bind to the CRE but not to an AP-1 or C/EBP site. Although sequence similarity within the basic domain clearly places BBF-2 in the bZIP family of DNA-binding proteins, BBF-2 does not contain a perfect heptad repeat of leucine residues. In most cases, bZIP proteins have been shown to dimerize, with their dimerization specificity determined by the leucine zipper (for review, see Abel and Maniatis 1989) . In the sequence of BBF-2, a tyrosine is substituted for the third leucine residue, creating the heptad repeat L-X^-L-X^-Y-X^-L-X^-L. This tyrosine substitution, however, does not adversely affect the ability of BBF-2 to dimerize via this domain (T. Abel and T. Maniatis, unpubl.) . This is consistent with the observation that a mutant form of the leucine zipper of GCN4 containing a tyrosine in place of this leucine residue can still dimerize (Hu et al. 1990 ). The dimerization of BBF-2 raises the possibility that BBF-2 may form specific heterodimers with other bZIP proteins and that these interactions may play a role in regulating its function. The observation of three BBF-2-containing complexes in gel retardation assays using ovarian nuclear extracts suggests that BBF-2 may interact with other proteins. Alternatively, these complexes may contain modified forms of BBF-2 or proteins that are immunologically related to BBF-2.
BBF-2 may play an essential role in Drosophila fat body-specific gene expression
We have shown that BBF-2 binds specifically to four different fat body enhancers: both the larval and adult fat (Fig. 2) were ahgned, and a comparison of these sequences is shown here. The Dwsophila orena { -565 to -555; Moses et al. 1990 ) and D. navojoa (nucleotides 1066-1076; the TATA box is at nucleotide 1335; Weaver et al. 1989 ) Adh sequences shown were identified by homology searches. The D. orena site corresponds to a site protected against DNase I cleavage by D. melanogaster embryonic nuclear extract (Moses et al. 1990 ). The human ADH-2 site is located between -62 and -72 of the promoter ). Binding of BBF-2 to this site has been confirmed by DNase I footprinting studies (data not shown). The TAT-CRE site is located in the CRE within the hepatocyte-specific enhancer of the TAT gene ) between -3651 and -3641. A consensus sequence can be derived (BBF-2) and this consensus is compared to the CREB (Montminy and Bilezikjian 1987) , AP-1 (Lee et al. 1987) , and C/EBP (S. McKnight, pers. comm.) consensus-binding sites.
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body enhancers of the D. mulleri Adh locus, the D. melanogaster adult Adh fat body enhancer, and the fat body enhancer of D. melanogaster yolk protein genes. Recently, Moses et al. (1990) used DNase I footprinting studies to investigate the interaction of factors present in embryonic nuclear extracts writh the promoter regions of the Adh genes from D. melanogaster and Drosophila orena. They observed extensive similarity of the protection patterns on the two promoters, a similarity that is reflected in the presence of short stretches of highly similar sequences. One of their footprints, d8, corresponds to the footprint of BBF-2, w^hich we have identified within the AAE (Figs. 2 and 8) . Thus, BBF-2 is likely to bind to most, if not all, Adh fat body-specific enhancers in Drosophila. Evidence for a functional role of BBF-2 binding to these enhancers is provided by the results of in vitro mutagenesis and P-element transformation experiments. Mutations in the BBF-2-binding sites of the the D. mulleri Adh-1 enhancer and the D. melanogaster adult enhancer disrupt BBF-2 binding in vitro and decrease the level of Adh gene expression in vivo (Fig. 5) . Taken together, these observations strongly suggest that BBF-2 plays an important role in the coordinate regulation of these enhancers in the fat body. The observation that BBF-2 mRNA is present throughout development and in the fat body is consistent with a role for BBF-2 in fat body gene expression. In addition, we have shown that BBF-2 can fimction as a transcriptional activator in transient cotransfection assays. Our cotransfection experiments have demonstrated that endogenous BBF-2 plays a role in the activity of box B in Schneider cells, as the introduction of an effector plasmid expressing antisense BBF-2 transcripts reduces the transcriptional activity of box B.
The fact that BBF-2 binds to fat body enhancers that are active in both larvae and adults, and the observation that BBF-2 mRNA is present in several tissues and at all developmental stages, suggest that BBF-2 may function as a ubiquitous activator of transcription. An additional possibility is that BBF-2 protein levels may be subject to translational control (as is the case for the liver-specific transcriptional activator DBF; Mueller et al. 1990) or that BBF-2 activity as a transcriptional activator may be subject to post-translational regulation (as is the case with CREB; . Studies are in progress to explore these possibilities. If BBF-2 is a ubiquitous transcriptional activator, then BBF-2 may be necessary but not sufficient for the temporal or tissuespecific patterns of Adh expression. Enhancer-promoter interactions Corbin and Maniatis 1989a) and transcriptional interference (Corbin and Maniatis 1989b) have been implicated in determining the normal temporal expression of Adh.
In summary, a number of observations are consistent with the possibility that BBF-2 plays an important role in fat body-specific gene expression. However, we cannot rule out the possibility that an as yet unidentified CREB/ ATF protein, or a heterodimer between BBF-2 and another CREB/ATF family member, may actually be involved. We have shown that BBF-2 lies in a region of the Drosophila chromosome that is well characterized ge- netically (Lindsley and Zimm 1987; Ashbumer 1991) . Thus, it should be possible to use a genetic approach to definitively establish whether BBF-2 is required for fat body-specific expression.
Evolutionary conservation of mechanisms involved in fat body-and liver-specific gene expression
Detoxification of alcohol in mammals takes place primarily in the liver. The DNA sequences required for liver-specific expression of the human AdA gene ) and a number of other genes have been studied extensively (for review, see Johnson 1990) . Proteins that bind to these elements have been identified, purified, and cloned by several groups. At least four distinct protein factors that are abundant in the liver have been found thus far: CCAAT/enhancer binding protein, the original leucine zipper protein (C/EBP; Landschulz et al. 1988a ); HNF-1, a homeo domain protein (also called LFBl; Frain et al. 1989 ); HNF-3, a protein with sequence similarity to the Drosophila homeotic gene fork head (Lai et al. 1991) ; and HNF-4, a member of the steroid hormone receptor superfamily (Sladek et al. 1990) . In nonliver cells, many hepatocyte-specific genes are subject to negative control by one of the trans-dominant tissue-specific extinguisher loci Tse-1 (Thayer and Foumier 1989) and Tse-2 (Chin and Fournier 1989) .
A possible link between mechanisms involved in fat body-specific gene expression in Drosophila and liverspecific gene expression in mammals was provided by the observation that BBF-2 binds specifically to DNA sequences required for liver-specific expression of mammalian Adh and TAT genes. This link is strengthened by the finding that a regulatory unit containing a positive element that binds mammalian C/EBP and a negative element that binds Drosophila AEF-1 is also found in both fat body-and liver-specific regulatory elements (D. Falb and T. Maniatis, this issue) . Remarkably, all wellcharacterized adult fat body enhancers, as well as the human ADH2 promoter, contain an AEF-1-binding site. This negative regulatory element is always located directly adjacent to a positive regulatory element that binds mammalian C/EBP (D. Falb and T. Maniatis, this issue) . Thus, at least three distinct regulatory elements are required for both fat body-and liver-specific gene expression: two positive regulatory elements, one of which is recognized by BBF-2 and the other by C/EBP, and a negative regulatory element that binds AEF-1 (Fig.  9) . The combinatorial organization of regulatory elements necessary to achieve tissue-specific gene expression may therefore have originated early in metazoan evolution.
In light of the fact that BBF-2 is a member of the CREB/ATF family of proteins, it is intriguing to note that recent studies of liver-specific expression in mammals have revealed that a subset of liver-specific genes Cold Spring Harbor Laboratory Press on October 19, 2017 -Published by genesdev.cshlp.org Downloaded from is inducible via the cAMP pathway and is coordinately repressed by the tissue-specific extinguisher 1 {Tse-1; Boshart et al. 1990; Ruppert et al. 1990 ). Studies of the hepatocyte-specific enhancer of the TAT gene have demonstrated that its activity results from the mutual dependence of a CRE and a second essential and cell-specific element Weih et al. 1990) . In vivo footprinting studies indicate that Tse-1 acts by affecting protein binding at this CRE element . The CRE element is thus the target for repression in nonliver cells. The recent cloning of Tse-1 has revealed that it encodes a regulatory subunit of cAMPdependent protein kinase (Boshart et al. 1991; Jones et al. 1991) . Tissue-specific gene expression, in this case, is regulated by the tissue-specific absence of activation of a ubiquitously expressed factor, CREB. Our identification of BBF-2 and its sequence similarity to the CREB/ATF family of transcriptional regulatory proteins suggests that common molecular mechanisms may be involved in generating tissue-specific gene expression in the fat body and its functional mammalian analog, the liver.
Materials and methods
cDNA library screening
A multimerized probe prepared from a restriction fragment containing box B (-269 to -181 of the Adh-1 promoter) was labeled by nick translation (Maniatis et al. 1982 ) and used to screen a 9-to 12-hr embryonic cDNA library (Zinn et al. 1988) in \gtl 1 as described previously (Singh et al. 1988; Vinson et al. 1988) , but with the following modifications. After overlaying with IPTG-impregnated filters, the plates were incubated overnight at 37°C. BSA was used in place of Carnation nonfat dry milk, and salmon sperm DNA (10 M-g/ml) was added to the probe solution. Filters were exposed to DNA probe overnight at 4°C and then washed in six changes of binding buffer containing 0.25% BSA over a period of 30 min.
For the isolation of other cDNA clones, DNA hybridization screening was used (Maniatis et al. 1982) . cDNA clones were isolated from the 9-to 12-hr embryonic Xgtll library described above and from a 12-to 24-hr embryonic plasmid library (Brown and Kafatos 1988) . For these screenings, a random oligonucleotide-primed DNA probe (Feinberg and Vogelstein 1983) was used at 2 X 10^ cpm/ml.
DNA sequencing
All cDNA clones were subcloned into the polylinker of the plasmid pSP72 (Promega). A series of deletions from each end of these fragments was generated using exonuclease 111 (Henikoff 1987) . In some cases, the cDNA clones were also further subcloned using convenient restriction sites. Sequencing reactions were performed by double-stranded sequencing with either SP6 or T7 promoter primers using Sequenase (U.S. Biochemical) or Taq polymerase (Stratagene). Both strands of three independent isolates were sequenced in their entirety.
Bacterial protein and ovarian nuclear extract preparation
For expression in Escherichia coli, the £coRI fragment from X.BBF-2 (starting at amino acid 3) was subcloned in-frame into the translation vector pET-3b (Rosenberg et al. 1987) . These plasmids were transformed into the bacterial strain BL21(DE3), which contains the T7 RNA polymerase gene under lacUVS promoter control. Transformed bacteria were grown to ODgoo = 0.4, induced with 0.4 mM IPTG, grown for 2 hr, and harvested. Total bacterial protein was subsequently isolated as in Desplan et al. (1985) .
Ovarian follicles were isolated and nuclear extracts were prepared as described previously (Shea et al. 1990 ). About 5 (xg of this extract was used in each gel shift reaction.
Gel retardation assays
For gel retardation assays (Fried and Crothers 1981) , bacterial extracts or ovarian extracts (5 |xg) were incubated with 15,000 cpm (-0.5 ng) of ^^P-end-labeled box B (-269 to -181 of the Adh-1 promoter) or an end-labeled oligonucleotide containing a BBF-2-binding site (for the sequence of this oligonucleotide, see the details of the construction of the plasmid p28-merCAT, below) at room temperature in a 25-|xl reaction containing 3 |xg of poly[d(I-C)] (Pharmacia), 4 mM Tris (pH 7.5), 125 mM NaCl, 1 mM EDTA, 0.5 mM DTT, and 5% glycerol. Samples were then electrophoresed on a prerun 4% 0.5 x Tris-borate/EDTA nondenaturing polyacrylamide gel at 4°C and 100 V/cm.
Other probes for DNA-binding studies were synthesized as follows. A BamHl-Hindlll fragment containing sequences from -171 to -t-34 of the human Adh-2 promoter was removed from the plasmid ADH2-cat ( -171) (provided by G. Duester; Stewart et al. 1990 ) and end-labeled. For binding studies with the TAT CRE, an oligonucleotide identical to the Bl oligonucleotide described by Boshart et al. (1990) was synthesized and end-labeled. A CREB/ATF probe was synthesized by digesting pSP72/ATF [containing a consensus CREB/ATF site, AATTCTGACGT-CAG, subcloned into the EcoRl site of SP72 (Promega); provided by W. Du] with BamHl and Bgill and end-labeling.
DNase I footprinting
DNase I footprinting experiments were carried out as described (Fieberlein et al. 1985) , with the following modifications. Binding reactions of 15 ji,l containing varying amounts of bacterial extract, 2 |xl of polyvinyl alcohol (13.3%), 3 |xg of poly[d(I-C)] (Pharmacia), 4 mM Tris (pH 7.5), and 125 mM NaCl were incubated on ice for 20 min. At room temperature, a 35-|JL1 aliquot of 5 mM CaClj, 10 mM MgClj solution was then added, followed by the addition of 2.5 \JA oi DNase I diluted to 2 |xg/ml in cold FijO. After 1 min, 75 |xl of stop solution (1.7 M ammonium acetate, 2 jj,g glycogen) was added, followed by 200 |xl of phenolchloroform. Following ethanol precipitation, the pellet was resuspended in 2 |xl of 0.1 M NaOH, 4 | JL1 of loading dyes were added, and the DNAs were analyzed on an 8% polyacrylamide sequencing gel. Maxam-Gilbert sequencing ladders were run on the gel as markers.
Antibody preparation and use
A rabbit polyclonal antibody to BBF-2 was prepared using gelpurified, bacterially produced full-length BBF-2 as an antigen. New Zealand white rabbits were injected three times at intervals of 3 weeks and serum was collected 2 weeks after the last injection for use in these experiments. For binding-inhibition experiments, serum was added to a standard gel-shift reaction containing extract and buffer, but no probe. After 20 min of incubation on ice, probe was added for an additional 20 min. The reaction was analyzed on a 4% 0.5 x Tris-borate/EDTA nondenaturing polyacrylamide gel.
Establishment and analysis of transformed Drosophila lines
The AAE/hs/lacZ construct used in this work has been described by Falb (1991) . It contains -615 to -473 of the D. melanogaster Adh gene fused to -43 of the hsplO promoter, which drives the expression of lacZ. This fusion gene was inserted into the Xha site within the P-element transformation vector C70Tx . A linker-scanning mutant in the BBF-2-binding site was obtained by site-directed mutagenesis (Taylor et al. 1985 ; Amersham) of the 143-bp AAE. The BBF-2 site was mutated using the following oligonucleotide, with the altered bases underlined: -587 TCCCAGTCACAG-TATTGATATCTTGCAAATTAAGCCGA -550. Mutagenized clones were verified by dideoxynucleotide sequencing, fused to the hsp70-lacZ reporter gene, and inserted into C70Tx.
Transformation vectors, along with the helper plasmid p25.7wc (Karess and Rubin 1984) , were injected into ry^°^ embryos using standard procedures (Rubin and Spradling 1982; Spradling and Rubin 1982) . Transformants were inbred to obtain homozygous lines.
Total nucleic acid was purified from 3-to 5-day-old adult flies as described previously (Fischer and Maniatis 1986) . Continuously labeled RNA probes were prepared from the plasmids pSP6-hslac ) and pSP6aTUB (Corbin and Maniatis 1989a) as described previously (Melton et al. 1984) . RNase mapping experiments were carried out as described below.
Northern analysis and RNase mapping
Poly(A)'^ RNA was selected from total RNA prepared from Drosophila at various developmental stages (Jowett 1986) . Two micrograms of poly(A)'^ RNA was fractionated on an agarose gel, and Northern analysis was carried out (Maniatis et al. 1982 ) using a random oligonucleotide-primed DNA probe (Feinberg and Vogelstein 1983) prepared from the £coRI insert of the cDNA clone \BBF-2.
For the analysis of BBF-2 expression in various tissues, total nucleic acid was purified from isolated tissues of early thirdinstar larvae as described previously (Fischer and Maniatis 1986) . Continuously labeled single-stranded RNA probes were prepared (Melton et al. 1984 ) from the plasmid pSP6aTUB (Corbin and Maniatis 1989a) , which was linearized with Hinfl to generate a 97-bp protected region, and pSP(261)BBF-2, which contains a 261-bp HincU-BamHl fragment corresponding to nucleotides 1150-1411 of BBF-2. Quantitative RNase mapping experiments were carried out as described previously (Zirm et al. 1983) , except that hybridizations were performed at 42°C without prior heating to 85°C, and RNase digestions were done at 30°C for 30 min. The protected fragments were fractionated on a 5% polyacrylamide sequencing gel and visualized by autoradiography.
fied by DNA sequencing and confirmed by in vitro translation using reticulocyte lysate. A Hindlll-Xhal fragment that contains the myc-BBF-2 fusion gene was subcloned into the BamHi site in the effector plasmid pPac (Krasnow et al. 1989) in both the sense (pPacBBF-2) and antisense (pPacBBF-2a) orientation. In this plasmid, expression is driven by the actinSC promoter and transcripts are terminated at actinSC polyadenylation sites.
Reporter plasmids were derived from pD-33CAT (Krasnow et al. 1989 ) except that the Xbal site was filled in with Klenow and a Bglll linker was inserted. This plasmid contains sequences extending from -33 to -1-53 of the D. melanogaster Adh distal promoter fused to the bacterial gene CAT. pBoxBCat was constructed by inserting a BamHl-Bglll fragment containing box B (-269 to -181 of the Adh-1 promoter) into this Bgill site. p28-merCAT was constructed by inserting an oligonucleotide encompassing the footprint of BBF-2 on box B into this Bglll site. This oligonucleotide includes the region from -269 to -242 of box B with a BamHl site added to the 5' end and a Bglll site at the 3' end. The sequence is GATCCTGTACACGT AATCG-TACGCGACGCCAGCA, where the hnker sequences at each end are underlined.
Schneider cell transfections
Schneider line 2 cells (Schneider 1972) were grown as described previously (DiNocera and Dawid 1983) except that the growth medium contained 12% heat-inactivated fetal bovine serum. Cells were passaged every 3 days and maintained at 25°C in 9-cm tissue culture plates at a density of 1 x 10^ to 8 x 10^ cells/ml. For transfection, cells were plated at a density of 1 X 10^ cells/ml in 6-well tissue culture dishes. Twenty-four hours later, the cells were transfected with 5 ixg of supercoiled plasmid DNA per well by the calcium phosphate technique (Graham and van der Eb 1973; Chen and Okayama 1988) . The cells were incubated with the precipitates at 25°C for 58-62 hr. Each transfection contained 5 |xg of expressor plasmid, 0.25 jig of reporter plasmid, and 0.2 |xg of hsp821acZ. The plasmid hsp82lacZ (provided by A. Ephrussi) contains the Drosophila hsp82 promoter driving expression of lacZ, and it was included as a control for transfection efficiency. Transfected cells were harvested, washed twice with PBS, and resuspended in 200 |xl of 0.25 M Tris-HCl (pH 7.8). p-Galactosidase activities were determined as described previously (Miller 1972) , typically using 5 jxl of extract and incubating at room temperature for 15 min. Cell lysates were heated to 65°C for 5 min, and CAT enzyme activities were assayed (Gorman et al. 1982) . The amovmt of extract (5-25 |xl) used in each CAT assay was normalized based on the p-galactosidase activity. The reaction products were separated by thin-layer chromatography (TLC). The percent conversion (%) of ''^C-labeled chloramphenicol to monoacetylated forms was calculated by scintillation counting of the substrate and product spots cut out of the TLC plate.
Plasmid constructions
For expression in tissue culture cells, the £coRI-£coRV fragment of BBF-2 (extending from nucleotide 932 to 2504, beginning at aI^ino acid 3) was first subcloned in-frame into the plasmid bs-myc. This plasmid was constructed by inserting a Hindis.-EcoRL fragment containing the c-myc tag (Munro and Pelham 1987) into HindIII-£coRI-cut pBluescript SK (Stratagene). The sequence of this fragment is AAGCTTGGGC-GACCTCACCATGGAGCAAAAGCTCATTTCTG AAGAG-GACTTGAATTC. This fragment provides a eukaryotic initiator codon (underlined; Cavener 1987) , and it encodes the amino acids MEQKLISEEDLN. The frame of this construct was veri-Cold Spring Harbor Laboratory Press on October 19, 2017 -Published by genesdev.cshlp.org Downloaded from payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.
Note added in proof
The nucleotide sequence data reported in this paper have been submitted to the EMBL/GenBank DDBJ nucleotide sequence data bases.
